These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Relevance of latent TB infection in areas of high TB prevalence. Sharma SK, Mohanan S, Sharma A. Chest; 2012 Sep; 142(3):761-773. PubMed ID: 22948580 [Abstract] [Full Text] [Related]
5. National position statement for the management of latent tuberculosis infection. Stock D, National Tuberculosis Advisory Committee. Commun Dis Intell Q Rep; 2017 Sep 01; 41(3):E204-E208. PubMed ID: 29720068 [Abstract] [Full Text] [Related]
6. Identifying components for programmatic latent tuberculosis infection control in the European Union. Sandgren A, Vonk Noordegraaf-Schouten JM, Oordt-Speets AM, van Kessel GB, de Vlas SJ, van der Werf MJ. Euro Surveill; 2016 Aug 25; 21(34):. PubMed ID: 27589214 [Abstract] [Full Text] [Related]
14. Updates on the risk factors for latent tuberculosis reactivation and their managements. Ai JW, Ruan QL, Liu QH, Zhang WH. Emerg Microbes Infect; 2016 Feb 03; 5(2):e10. PubMed ID: 26839146 [Abstract] [Full Text] [Related]